期刊文献+

Livin与Caspase-9在胃癌组织中的表达及临床意义 被引量:1

Expression and Clinical Significance of Livin and in Caspase-9 in Gastric Carcinoma
下载PDF
导出
摘要 目的为探讨Livin和Caspase-9在胃癌组织中的表达及临床意义。方法采用免疫组化染色方法检测56例胃癌组织及56例正常胃黏膜中Livin和Caspase-9的蛋白表达。结果胃癌标本Livin和Caspase-9的阳性表达率分别为68%、18%,与正常胃黏膜阳性表达率(5.4%、62.5%)比较有显著性差异(P<0.05)。Livin的表达,随着胃癌病理变化进展、程度的发展,阳性表达率增高,Caspase-9的表达,随着胃癌病理变化进展、程度的发展,阳性表达率降低,两者比较有显著性差异(P<0.05)。组织标本中Livin和Caspase-9表达呈负相关性。结论Livin和Caspase-9在胃癌的发生、发展中起着重要的作用,可能会成为胃癌的分子标志物或胃癌治疗的新分子靶点。 Objective To investigate the expression and the clinical significance of Livin and Caspase-9 in gastric carcinoma.Methods 56 cases were selected separately in gastric carcinoma and normal gastric mucous membrane in evaluate the expressions of Livin and Caspase-9 by immunohistochemical technique.Results The rate of positive expression of Livin and Caspase-9 in gastric carcinoma was seperately 68%、18%and had significant difference compared with normal gastric mucous membrane(seperately 5.4%,62.5%,P〈0.05).The rate of positive expression of Livin gradually increased along with advancement of gastric carcinoma pathological change,while Caspase -9 gradually decreased along with advancement of gastric carcinoma pathological change and both have significant difference(P〈0.05).The expression of Livin and Caspase-9 had negative correlation in tissue specimens. Conclusion Livin and Caspase-9 might play an important role in occurrence and development of the gastric carcinoma.They perhapes became molecule marker or new molecule target of the gastric cancer therapeutic.
作者 孟宪红 阎磊
出处 《黑龙江医学》 2010年第1期4-6,共3页 Heilongjiang Medical Journal
关键词 LIVIN CASPASE-9 胃癌 免疫组化 Livin Caspase-9 Gastric carcinoma
  • 相关文献

参考文献7

  • 1Kasof G M, Gomes B C. Livin, a novel inhibitor of apoptosis protein family member [ j ]. J Biol Chem,2001,276(5 ) :3 238 - 3 246.
  • 2Salvesen G S, Duckett C S. IAP proteins: blocking the road to deaths door[J]. Nat Rev Mol Cell Biol, 2002,3 (6) :401 - 410.
  • 3Hariu H, Hirohashi Y, Torigoe T, et al. Aberrant expression and potency as a cancer immunotherapy target of inhibitor of apoptosis protein family, Livin/ ML-IAP in lung cancer [ J ]. Clin Cancer Res,2005, 11(3) :1 000- 1 009.
  • 4Takeuchi H, Kim J, Fujimoto A, et al. X - linked inhibitor of apoptosis protein expression level in colorectal cancer is regulated by hepatocyte growth factor/C -met pathway via Akt signaling[ J ]. Clin Cancer Res,2005,11 (21):7 621 -7 628.
  • 5Yagihash I A, Asanuma K, Tsuj I N, et al.Detection of anti - Livin antibody in gastro intestinal cancer patients [ J ]. Clin Chem, 2003,49 (7) : 1 206 -1 208.
  • 6Kasof G M, Gomes B C. Livin, a novel inhibitor of apoptosis protein family member[ J ]. Biol Chem, 2001,276(5 ) :3 238 -46.
  • 7Vucic D, Stennicke H R, Pisabarro M T, et al. ML - IAP, a novel inhibitor of apoptosis that is preferentially cxpressed in human melanomas[ J ]. Curr Biol,2000,10(21 ) :1 359 -66.

同被引文献3

引证文献1

二级引证文献2

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部